Antibiotic Resistance, Drug Prescribing Trends To Be Tracked By Database
Executive Summary
An FDA-contracted database will track emerging antibiotic resistance patterns and physician prescribing patterns
You may also be interested in...
Antibiotic Research Stalling In Conversion Of Target Into New Drug
Translating validated targets into clinical candidates is the major hurdle in discovering new antibiotics to combat resistance, Lilly VP-Scientific Affairs Gail Cassell, PhD, suggested in a presentation to FDA's Center for Drug Evaluation & Research Jan. 7
Antibiotic Research Stalling In Conversion Of Target Into New Drug
Translating validated targets into clinical candidates is the major hurdle in discovering new antibiotics to combat resistance, Lilly VP-Scientific Affairs Gail Cassell, PhD, suggested in a presentation to FDA's Center for Drug Evaluation & Research Jan. 7
Cubist Cubicin Marketing To Highlight Single Daily Dose Of Antibiotic
Cubist's Cubicin (daptomycin) will be promoted for its single daily dosing compared to traditional antibiotics administered at least twice daily